TP53 and neoplasm: Based on the literature and our current findings, further investigation is necessary to understand the relation between BRD4 and p53 in order to validate the hypothesis that ABBV-744 may be disrupting the connection between p53 and BRD4, thereby affecting tumor cell growth.